The national peak body for health and medical research and innovation, Research Australia welcomes the Federal Government’s Medical Science Co-Investment Plan which will strengthen collaboration between government and industry.
Research Australia has been working with the sector to look at ways that government can better work with industry, including through new government procurement measures.
“Australia’s health and medical research sector is one of the strongest in the world – ranking 7th in the world – with health and medical research accounting for 23% of all R&D investment”, Research Australia’s CEO & Managing Director, Nadia Levin said.
“Research Australia welcomes the Medical Science Co-Investment Plan announced yesterday by Minister Husic and Minister Butler and strongly supports some of the areas of potential investment opportunity identified, such as digital health, medical devices, innovative therapeutics and sustainability.”
“There is not only a clear health benefit to investing in health and medical research and innovation but a strong economic benefit, including through the creation of jobs and boosting our economy and local industry”, Ms. Levin said.
Research Australia looks forward to continuing to work with the Federal Government on key policy reforms needed to strengthen Australia’s health and medical research and innovation sector.
This will include convening a Pre-Election Summit on 8 October 2024 in Canberra, bringing together the health and medical research sector to discuss key policy reforms ahead of the next Federal Election.
Research Australia is the national peak body representing all stages of the health and medical research and innovation sector. We represent over 150 organisations across the entire pipeline of research and commercialisation with members including universities, medical research institutes, medical technology companies, pharmaceutical companies, and consumer organisations.
ENDS
